Cargando…
First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573942/ https://www.ncbi.nlm.nih.gov/pubmed/36262114 http://dx.doi.org/10.3389/ti.2022.10846 |
_version_ | 1784810989319880704 |
---|---|
author | Jehn, Ulrich Altuner, Ugur Pavenstädt, Hermann Reuter, Stefan |
author_facet | Jehn, Ulrich Altuner, Ugur Pavenstädt, Hermann Reuter, Stefan |
author_sort | Jehn, Ulrich |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9573942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95739422022-10-18 First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient Jehn, Ulrich Altuner, Ugur Pavenstädt, Hermann Reuter, Stefan Transpl Int Health Archive Frontiers Media S.A. 2022-10-03 /pmc/articles/PMC9573942/ /pubmed/36262114 http://dx.doi.org/10.3389/ti.2022.10846 Text en Copyright © 2022 Jehn, Altuner, Pavenstädt and Reuter. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Health Archive Jehn, Ulrich Altuner, Ugur Pavenstädt, Hermann Reuter, Stefan First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient |
title | First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient |
title_full | First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient |
title_fullStr | First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient |
title_full_unstemmed | First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient |
title_short | First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient |
title_sort | first report on successful conversion of long-term treatment of recurrent atypical hemolytic uremic syndrome with eculizumab to ravulizumab in a renal transplant patient |
topic | Health Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573942/ https://www.ncbi.nlm.nih.gov/pubmed/36262114 http://dx.doi.org/10.3389/ti.2022.10846 |
work_keys_str_mv | AT jehnulrich firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient AT altunerugur firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient AT pavenstadthermann firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient AT reuterstefan firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient |